Concurrent Chemoradiotherapy With 5-Fluorouracil and Mitomycin C for Invasive Anal Carcinoma in Human Immunodeficiency Virus-Positive Patients Receiving Highly Active Antiretroviral Therapy

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 5, 2010, Pages 1425-1432

  Fraunholz, Ingeborg ^a   Weiss, Christian ^a   Eberlein, Klaus ^a   Haberl, Annette ^a   Rödel, Claus ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Anal carcinoma; chemoradiotherapy; HAART; highly active antiretroviral therapy; HIV; human immunodeficiency virus; toxicity

Indexed keywords

5-FLUOROURACIL; ACQUIRED IMMUNODEFICIENCY SYNDROME; ANAL CANCER; CANCER PROGRESSION; CHEMORADIOTHERAPY; CLINICAL OUTCOME; COMPLETE RESPONSE; CONCURRENT CHEMORADIOTHERAPY; DOSE REDUCTION; HAART; HIGHLY ACTIVE ANTI-RETROVIRAL THERAPIES; HUMAN IMMUNODEFICIENCY VIRUS; INFECTED PATIENTS; LOCAL CONTROL; MITOMYCIN C; OVERALL SURVIVAL; OVERALL SURVIVAL RATES; POST TREATMENT; PRE-TREATMENT; RETROSPECTIVE ANALYSIS; TUMOR RESPONSE; VIRAL LOAD;

CHEMOTHERAPY; FISH; FLUORESCENT SCREENS; TOXICITY; TUMORS;

VIRUSES;

FLUOROURACIL; MITOMYCIN C; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANUS CARCINOMA; ANUS FISTULA; ANUS ULCER; ARTICLE; BLOOD TOXICITY; BOWEN DISEASE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONDYLOMA; CONTINUOUS INFUSION; DERMATITIS; DIARRHEA; DISEASE SEVERITY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FIBROSIS; FOLLOW UP; GASTROINTESTINAL TOXICITY; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION; INTESTINE PERFORATION; INTESTINE ULCER; INVASIVE CARCINOMA; KIDNEY FAILURE; LEUKOPENIA; LYMPH NODE METASTASIS; MALE; MORBIDITY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; OVERALL SURVIVAL; PAIN; PELVIC FIBROSIS; PERIANAL ABSCESS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROCTITIS; RADIATION DERMATITIS; RADIATION DOSE; RADIATION ENTEROPATHY; RETROSPECTIVE STUDY; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; URETER STRICTURE; URINARY URGENCY; VIRUS LOAD; VOMITING;

ADULT; AGED; ANTI-HIV AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANUS NEOPLASMS; CD4 LYMPHOCYTE COUNT; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; RADIOTHERAPY, CONFORMAL; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VIRAL LOAD;

EID: 77949566454     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.03.060     Document Type: Article

References (29)

1. Bower M., Powles T., Newsom-Davis T., et al. HIV-associated anal cancer: Has highly active antiretroviral therapy reduced the incidence or improved the outcome?. J Acquir Immune Defic Syndr 37 (2004) 1563-1565
2. Melbye M., Cote T.R., Kessler L., et al., for the AIDS/Cancer Working Group. High incidence of anal cancer among AIDS patients. Lancet 343 (1994) 636-639
3. Fox P., Stebbing J., Portsmouth S., et al. Lack of response of anal intra-epithelial neoplasia to highly active antiretroviral therapy. AIDS 17 (2003) 279-280
4. Heard I., Palefsky J.M., and Kazatchkine M.D. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antivir Ther 9 (2004) 13-22
5. Frisch M., Biggar R.J., and Goedert J.J. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92 (2000) 1500-1510
6. UK Co-Ordinating Committee on Cancer Research Anal Cancer Trial Working Party. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 348 (1996) 1049-1054
7. Bartelink H., Roelofsen F., Eschwege F., et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15 (1997) 2040-2049
8. Flam M., John M., Pajak T.F., et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 14 (1996) 2527-2539
9. Ajani J.A., Winter K.A., Gunderson L.L., et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial. JAMA 299 (2008) 1914-1921
10. Chadha M., Rosenblatt E.A., Malamud S., et al. Squamous-cell carcinoma of the anus in HIV-positive patients. Dis Colon Rectum 37 (1994) 861-865
11. Peddada A.V., Smith D.E., Rao A.R., et al. Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 37 (1997) 1101-1105
12. Kao G.D., Devine P., and Mirza N. Oral cavity and oropharyngeal tumors in human immunodeficiency virus-positive patients: Acute response to radiation therapy. Arch Otolaryngol Head Neck Surg 125 (1999) 873-876
13. Watkins E.B., Findlay P., Gelmann E., et al. Enhanced mucosal reactions in AIDS patients receiving oropharyngeal irradiation. Int J Radiat Oncol Biol Phys 13 (1987) 1403-1408
14. Kim J.H., Sarani B., Orkin B.A., et al. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients. Dis Colon Rectum 44 (2001) 1496-1502
15. Place R.J., Gregorcyk S.G., Huber P.J., et al. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma. Dis Colon Rectum 44 (2001) 506-512
16. Hoffman R., Welton M.L., Klencke B., et al. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys 44 (1999) 127-131
17. Antoniou T., and Tseng A.L. Interactions between antiretrovirals and antineoplastic drug therapy. Clin Pharmacokinet 44 (2005) 111-145
18. Pajonk F., Himmelsbach J., Riess K., et al. The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells. Cancer Res 62 (2002) 5230-5235
19. Sparano J.A., Wiernik P.H., Hu X., et al. Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma. Med Oncol 15 (1998) 50-57
20. Brunner T.B., Geiger M., Grabenbauer G.G., et al. Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer. J Clin Oncol 26 (2008) 2699-2706
21. Chiao E.Y., Giordano T.P., Richardson P., et al. Human immunodeficiency virus-associated squamous cell cancer of the anus: Epidemiology and outcomes in the highly active antiretroviral therapy era. J Clin Oncol 26 (2008) 474-479
22. Blazy A., Hennequin C., Gornet J.M., et al. Anal carcinomas in HIV-positive patients: High-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy. Dis Colon Rectum 48 (2005) 1176-1181
23. Cleator S., Fife K., Nelson M., et al. Treatment of HIV-associated invasive anal cancer with combined chemoradiation. Eur J Cancer 36 (2000) 754-758
24. Wexler A., Berson A.M., Goldstone S.E., et al. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy. Dis Colon Rectum 51 (2008) 73-81
25. Oehler-Jänne C., Huguet F., Provencher S., et al. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: A multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy. J Clin Oncol 26 (2008) 2550-2557
26. Holland J.M., and Swift P.S. Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy. Radiology 193 (1994) 251-254
27. Stadler R.F., Gregorcyk S.G., Euhus D.M., et al. Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy. Dis Colon Rectum 47 (2004) 1305-1309
28. Edelman S., and Johnstone P.A. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: Outcomes and toxicities. Int J Radiat Oncol Biol Phys 66 (2006) 206-211
29. Seo Y., Kinsella M.T., Reynolds H.L., et al. Outcomes of chemoradiotherapy with 5-fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients. Int J Radiat Oncol Biol Phys (2009) In press